Skip to main content
Stonvex
Loading…
Home
Markets
Screener
Portfolio
Community
Stonvex publishes market data and research only.
Not investment advice. Not a registered investment advisor.
Read disclaimer
.
Stonvex
Search…
⌘K
Search…
⌘K
← Back to rankings
GALT
Live
Save
Overview
Financials
Filings
Earnings Calls
Short Interest
Ownership
Ratings
Peers
News
Log in
Get Started
Loading latest news…
52w high -69.3%
☁️ News word cloud
Top words across the last 50 articles for this ticker.
high
nyse
nasdaq
therapeutics
galectin
thursday
results
morning
traded
close
session
change
liver
after
gained
reported
2023
target
announced
yearly
GALT
Galectin Therapeutics Inc.
StonvexStonvexStonvexStonvex